COVID-19 vaccine developers to use mRNA technology for better shingles inoculation

By Cassidy Morrison

Published January 21, 2022 4:00am ET

COVID-19 vaccine developers to use mRNA technology for better shingles inoculation — U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses. | kaptnali

Researchers at Pfizer and BioNTech said they believe they can make an even better vaccine for shingles using promising messenger RNA technology perfected in their COVID-19 shots.

Clinical trials of the vaccine for shingles, a debilitating disease triggered by a chronic form of the virus that causes chickenpox, will begin in the second half of the year, according to an announcement from the companies.